Summary
98.11
2.27
(2.37%)
04/13/2026
Mesa Laboratories, Inc. (MLAB)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years |
| 2.37 | 1.68 | 30.88 | 14.34 | 42.01 | -12.11 | -60.09 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan!
Fundamental Ratings
| Category | Rating |
| Main Rating | B- |
| Recommended Rating | Neutral |
| DCF | Strong Buy |
| ROE | Sell |
| ROA | Neutral |
| Debt/Equity | Strong Sell |
| P/E | Strong Sell |
| P/B | Neutral |
Earnings
| Trading Data | ||
| Close | 98.11 | |
| Open | 95.67 | |
| High | 98.29 | |
| Low | 95.47 | |
| Volume | 64,731 | |
| Change | 2.27 | |
| Change % | 2.37 | |
| Avg Volume (20 Days) | 116,449 | |
| Volume/Avg Volume (20 Days) Ratio | 0.56 | |
| 52 Week Range | 55.12 - 130.23 | |
| Price vs 52 Week High | -24.66% | |
| Price vs 52 Week Low | 78.00% | |
| Range | 2.29 | |
| Gap Up/Down | 0.44 | |
Profitibility | ||
| Market Capitalization (Mln) | 441 | |
| Revenue per share | 44.7471 | |
| Net Income per share | 0.6750 | |
| Dividend Yield | 0.0067 | |
| Dividend Share | 64.00% | |
Valuations | ||
| Enterprise Value | 0.00% | |
| PE Ratio | 141.9890 | |
| PB Ratio | 0.0000 | |
| PTB Ratio | 0.0000 | |
Liquidity | ||
| Debt/Equity Ratio | 0.0000 | |
| Net Debt/EBIDTA Ratio | 0.0000 | |
| Current Ratio | 0.0000 | |
Enterprise Value and Cash Flow | ||
| EV/Sales Ratio | 0.0000 | |
| EV/EBIDTA Ratio | 0.0000 | |
| EV/Free Cash Flow Ratio | 0.0000 | |
04/02 18:00 EST - globenewswire.com
MESA LABS DECLARES QUARTERLY DIVIDEND
LAKEWOOD, Colo. , April 02, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0. 16 per share of common stock. The dividend will be payable on June 15,...
MESA LABS DECLARES QUARTERLY DIVIDEND
LAKEWOOD, Colo. , April 02, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0. 16 per share of common stock. The dividend will be payable on June 15,...
03/25 02:58 EST - defenseworld.net
Mesa Laboratories (NASDAQ:MLAB) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened
Mesa Laboratories, Inc. (NASDAQ: MLAB - Get Free Report)'s stock price passed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $79.16 and traded as high as $82.50. Mesa Laboratories shares last traded at $81.13, with a volume of...
Mesa Laboratories (NASDAQ:MLAB) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened
Mesa Laboratories, Inc. (NASDAQ: MLAB - Get Free Report)'s stock price passed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $79.16 and traded as high as $82.50. Mesa Laboratories shares last traded at $81.13, with a volume of...
03/09 03:55 EST - seekingalpha.com
Royce Small-Cap Fund FY 2025: What Worked
Five of the Fund's 10 equity sectors made a positive impact on calendar year performance, led by Industrials, Financials, and Information Technology. Alamos Gold's positive earnings outlook, a renewed stock buyback program, and rising gold prices all helped its stock to climb throughout 2025....
Royce Small-Cap Fund FY 2025: What Worked
Five of the Fund's 10 equity sectors made a positive impact on calendar year performance, led by Industrials, Financials, and Information Technology. Alamos Gold's positive earnings outlook, a renewed stock buyback program, and rising gold prices all helped its stock to climb throughout 2025....
02/19 03:26 EST - defenseworld.net
Principal Financial Group Inc. Decreases Stock Holdings in Mesa Laboratories, Inc. $MLAB
Principal Financial Group Inc. lessened its stake in Mesa Laboratories, Inc. (NASDAQ: MLAB) by 66.2% in the undefined quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 10,065 shares of the medical instruments supplier's stock after selling...
Principal Financial Group Inc. Decreases Stock Holdings in Mesa Laboratories, Inc. $MLAB
Principal Financial Group Inc. lessened its stake in Mesa Laboratories, Inc. (NASDAQ: MLAB) by 66.2% in the undefined quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 10,065 shares of the medical instruments supplier's stock after selling...
02/09 05:05 EST - defenseworld.net
Mesa Laboratories, Inc. $MLAB Shares Bought by Diamond Hill Capital Management Inc.
Diamond Hill Capital Management Inc. grew its holdings in shares of Mesa Laboratories, Inc. (NASDAQ: MLAB) by 218.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 123,381 shares of the medical instruments...
Mesa Laboratories, Inc. $MLAB Shares Bought by Diamond Hill Capital Management Inc.
Diamond Hill Capital Management Inc. grew its holdings in shares of Mesa Laboratories, Inc. (NASDAQ: MLAB) by 218.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 123,381 shares of the medical instruments...
01/27 03:26 EST - defenseworld.net
Mesa Laboratories (MLAB) to Release Quarterly Earnings on Tuesday
Mesa Laboratories (NASDAQ: MLAB - Get Free Report) is projected to issue its Q3 2026 results before the market opens on Tuesday, February 3rd. Analysts expect the company to announce earnings of $2.41 per share and revenue of $63.2330 million for the quarter. Individuals may visit the the company's...
Mesa Laboratories (MLAB) to Release Quarterly Earnings on Tuesday
Mesa Laboratories (NASDAQ: MLAB - Get Free Report) is projected to issue its Q3 2026 results before the market opens on Tuesday, February 3rd. Analysts expect the company to announce earnings of $2.41 per share and revenue of $63.2330 million for the quarter. Individuals may visit the the company's...
01/15 01:55 EST - seekingalpha.com
Mesa Laboratories, Inc. (MLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Mesa Laboratories, Inc. (MLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Mesa Laboratories, Inc. (MLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Mesa Laboratories, Inc. (MLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
12/18 19:00 EST - globenewswire.com
Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
LAKEWOOD, Colo., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens, President and CEO, and John Sakys, CFO will present at the 44th...
Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
LAKEWOOD, Colo., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens, President and CEO, and John Sakys, CFO will present at the 44th...
11/30 02:26 EST - defenseworld.net
Financial Review: Accuray (NASDAQ:ARAY) & Mesa Laboratories (NASDAQ:MLAB)
Mesa Laboratories (NASDAQ: MLAB - Get Free Report) and Accuray (NASDAQ: ARAY - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation,...
Financial Review: Accuray (NASDAQ:ARAY) & Mesa Laboratories (NASDAQ:MLAB)
Mesa Laboratories (NASDAQ: MLAB - Get Free Report) and Accuray (NASDAQ: ARAY - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation,...
11/12 15:14 EST - globenewswire.com
Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences
LAKEWOOD, Colo., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that Gary Owens, President and CEO, and John Sakys, CFO will be attending the following upcoming conferences:
Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences
LAKEWOOD, Colo., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that Gary Owens, President and CEO, and John Sakys, CFO will be attending the following upcoming conferences:
10/03 11:46 EST - globenewswire.com
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025
LAKEWOOD, Colo., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the second quarter of fiscal year 2026 following market close on Thursday, November 6, 2025.
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025
LAKEWOOD, Colo., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the second quarter of fiscal year 2026 following market close on Thursday, November 6, 2025.
09/22 07:56 EST - zacks.com
Mesa Labs (MLAB) Stock Jumps 5.7%: Will It Continue to Soar?
Mesa Labs (MLAB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Mesa Labs (MLAB) Stock Jumps 5.7%: Will It Continue to Soar?
Mesa Labs (MLAB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
08/18 14:01 EST - globenewswire.com
Mesa Laboratories Executes Previously-Announced Strategic Financing Plan
LAKEWOOD, Colo., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, “Mesa” or the “Company”) today announced that it has executed on its previously-announced financial strategy, repaying $97.5 million aggregate principal of the Company's 1.375%...
Mesa Laboratories Executes Previously-Announced Strategic Financing Plan
LAKEWOOD, Colo., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, “Mesa” or the “Company”) today announced that it has executed on its previously-announced financial strategy, repaying $97.5 million aggregate principal of the Company's 1.375%...
08/05 10:15 EST - zacks.com
Mesa Labs (MLAB) Lags Q1 Earnings and Revenue Estimates
Mesa Labs (MLAB) came out with quarterly earnings of $2.32 per share, missing the Zacks Consensus Estimate of $2.46 per share. This compares to earnings of $2.83 per share a year ago.
Mesa Labs (MLAB) Lags Q1 Earnings and Revenue Estimates
Mesa Labs (MLAB) came out with quarterly earnings of $2.32 per share, missing the Zacks Consensus Estimate of $2.46 per share. This compares to earnings of $2.83 per share a year ago.
07/02 15:20 EST - globenewswire.com
Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025
LAKEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern time on Tuesday, August 5, 2025.
Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025
LAKEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern time on Tuesday, August 5, 2025.
05/28 10:16 EST - zacks.com
Mesa Labs (MLAB) Q4 Earnings and Revenues Lag Estimates
Mesa Labs (MLAB) came out with quarterly earnings of $2.23 per share, missing the Zacks Consensus Estimate of $2.75 per share. This compares to earnings of $2.77 per share a year ago.
Mesa Labs (MLAB) Q4 Earnings and Revenues Lag Estimates
Mesa Labs (MLAB) came out with quarterly earnings of $2.23 per share, missing the Zacks Consensus Estimate of $2.75 per share. This compares to earnings of $2.77 per share a year ago.
05/28 08:00 EST - globenewswire.com
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results
LAKEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q25”) and full fiscal year (“FY25”)...
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results
LAKEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q25”) and full fiscal year (“FY25”)...
Market News
×
Loading news…